GB9404046D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number: GB9404046D0
Authority: GB; United Kingdom
Prior art keywords: novel compounds; novel; compounds
Prior art date: 1994-03-03
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

GB9404046A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

SmithKline Beecham Corp

Original Assignee

SmithKline Beecham Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-03-03

Filing date

1994-03-03

Publication date

1994-04-20

1994-03-03 Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp

1994-03-03 Priority to GB9404046A priority Critical patent/GB9404046D0/en

1994-04-20 Publication of GB9404046D0 publication Critical patent/GB9404046D0/en

1995-03-03 Priority to US08/702,528 priority patent/US5665753A/en

1995-03-03 Priority to JP7523024A priority patent/JPH09509940A/en

1995-03-03 Priority to PCT/US1995/002606 priority patent/WO1995023790A1/en

1995-03-03 Priority to EP95912688A priority patent/EP0748313A4/en

Status Pending legal-status Critical Current

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/68—Halogen atoms

GB9404046A 1994-03-03 1994-03-03 Novel compounds Pending GB9404046D0 (en)

Priority Applications (5)

Application Number	Priority Date	Filing Date	Title
GB9404046A GB9404046D0 (en)	1994-03-03	1994-03-03	Novel compounds
US08/702,528 US5665753A (en)	1994-03-03	1995-03-03	Cytokine inhibiting imidazole substituted hydroxamic acid derivatives
JP7523024A JPH09509940A (en)	1994-03-03	1995-03-03	Cytokine-inhibiting imidazole-substituted hydroxamic acid derivatives
PCT/US1995/002606 WO1995023790A1 (en)	1994-03-03	1995-03-03	Cytokine inhibiting imidazole substituted hydroxamic acid derivatives
EP95912688A EP0748313A4 (en)	1994-03-03	1995-03-03	Cytokine inhibiting imidazole substituted hydroxamic acid derivatives

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB9404046A GB9404046D0 (en)	1994-03-03	1994-03-03	Novel compounds

Publications (1)

Publication Number	Publication Date
GB9404046D0 true GB9404046D0 (en)	1994-04-20

Family

ID=10751186

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GB9404046A Pending GB9404046D0 (en)	1994-03-03	1994-03-03	Novel compounds

Country Status (4)

Country	Link
EP (1)	EP0748313A4 (en)
JP (1)	JPH09509940A (en)
GB (1)	GB9404046D0 (en)
WO (1)	WO1995023790A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9601042D0 (en) *	1996-01-17	1996-03-20	Smithkline Beecham Plc	Medical use
US5703092A (en) *	1995-04-18	1997-12-30	The Dupont Merck Pharmaceutical Company	Hydroxamic acid compounds as metalloprotease and TNF inhibitors
WO1997019075A1 (en) *	1995-11-22	1997-05-29	Darwin Discovery Limited	Mercaptoalkylpeptidyl compounds having an imidazole substituent and their use as inhibitors of matrix metalloproteinases (mmp) and/or tumour necrosis factor (tnf)
US6127427A (en)	1995-11-23	2000-10-03	British Biotech Pharmaceuticals Limited	Metalloproteinase inhibitors
US6566384B1 (en)	1996-08-07	2003-05-20	Darwin Discovery Ltd.	Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity
DE69729007T2 (en) *	1996-08-07	2005-04-07	Darwin Discovery Ltd., Slough	HYDROXAMIC ACID AND CARBOXYLIC DERIVATIVES WITH MMP AND TNF HEMMENDER EFFECT
US6462023B1 (en)	1996-09-10	2002-10-08	British Biotech Pharmaceuticals, Ltd.	Cytostatic agents
ATE220660T1 (en)	1996-09-10	2002-08-15	British Biotech Pharm	CYTOSTATIC HYDROXAMIC ACID DERIVATIVES
US5952320A (en) *	1997-01-07	1999-09-14	Abbott Laboratories	Macrocyclic inhibitors of matrix metalloproteinases and TNFα secretion
US5985911A (en) *	1997-01-07	1999-11-16	Abbott Laboratories	C-terminal ketone inhibitors of matrix metalloproteinases and TNFα secretion
US6329418B1 (en)	1998-04-14	2001-12-11	The Procter & Gamble Company	Substituted pyrrolidine hydroxamate metalloprotease inhibitors
US6288261B1 (en)	1998-12-18	2001-09-11	Abbott Laboratories	Inhibitors of matrix metalloproteinases
EP1339400B1 (en)	2000-11-23	2005-06-29	Vernalis (Oxford) Ltd	N-formyl hydroxylamine derivatives as inhibitors of bacterial polypeptide deformylase for treating microbial infections
GB0031321D0 (en) *	2000-12-21	2001-02-07	Pfizer Ltd	Treatment
US6716861B2 (en)	2000-12-21	2004-04-06	Pfizer, Inc.	3-ox(adi)azolylpropanohydroxamic acids useful as procollagen C-proteinase inhibitors
US6645993B2 (en)	2001-03-30	2003-11-11	Warner-Lambert Company	3-heterocyclylpropanohydroxamic acid PCP inhibitors
GB0204159D0 (en) *	2002-02-22	2002-04-10	British Biotech Pharm	Metalloproteinase inhibitors
WO2004101537A1 (en) *	2003-05-17	2004-11-25	British Biotech Pharmaceuticals Ltd	Metalloproteinase inhibitors
CN114957160A (en) *	2022-03-28	2022-08-30	北京理工大学	2,4, 5-trisubstituted thiazole compound, preparation method and application thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK77487A (en) *	1986-03-11	1987-09-12	Hoffmann La Roche	hydroxylamine
GB8827308D0 (en) *	1988-11-23	1988-12-29	British Bio Technology	Compounds
GB8827305D0 (en) *	1988-11-23	1988-12-29	British Bio Technology	Compounds
GB9102635D0 (en) *	1991-02-07	1991-03-27	British Bio Technology	Compounds
GB9215665D0 (en) *	1992-07-23	1992-09-09	British Bio Technology	Compounds
NZ262447A (en) *	1993-03-16	1996-07-26	British Biotech Pharm	Hydroxamic acid derivatives and their use as pharmaceutical agents

1994
- 1994-03-03 GB GB9404046A patent/GB9404046D0/en active Pending
1995
- 1995-03-03 WO PCT/US1995/002606 patent/WO1995023790A1/en not_active Application Discontinuation
- 1995-03-03 JP JP7523024A patent/JPH09509940A/en active Pending
- 1995-03-03 EP EP95912688A patent/EP0748313A4/en not_active Withdrawn

Also Published As

Publication number	Publication date
EP0748313A1 (en)	1996-12-18
WO1995023790A1 (en)	1995-09-08
EP0748313A4 (en)	1997-06-11
JPH09509940A (en)	1997-10-07

Publication	Publication Date	Title
GB9405019D0 (en)	1994-04-27	Novel compounds
GB9406498D0 (en)	1994-05-25	Novel compounds
GB9404046D0 (en)	1994-04-20	Novel compounds
EP0800389A4 (en)	1998-04-29	Novel compounds
GB9400889D0 (en)	1994-03-16	Novel compounds
GB9409718D0 (en)	1994-07-06	Novel compounds
GB9402542D0 (en)	1994-04-06	Novel compounds
GB9409581D0 (en)	1994-07-06	Novel compounds
GB9409070D0 (en)	1994-06-22	Novel compounds
GB9400592D0 (en)	1994-03-09	Novel compounds
GB9400591D0 (en)	1994-03-09	Novel compounds
GB9401511D0 (en)	1994-03-23	Novel compounds
GB9401549D0 (en)	1994-03-23	Novel compounds
GB9402195D0 (en)	1994-03-30	Novel compounds
GB9402198D0 (en)	1994-03-30	Novel compounds
GB9408786D0 (en)	1994-06-22	Novel compounds
GB9402199D0 (en)	1994-03-30	Novel compounds
GB9402200D0 (en)	1994-03-30	Novel compounds
GB9402341D0 (en)	1994-03-30	Novel compounds
GB9424183D0 (en)	1995-01-18	Novel compounds
GB9410781D0 (en)	1994-07-20	Novel compounds
GB9410780D0 (en)	1994-07-20	Novel compounds
GB9410506D0 (en)	1994-07-13	Novel compounds
GB9409717D0 (en)	1994-07-06	Novel compounds
GB9401139D0 (en)	1994-03-16	Novel compounds